Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Hong Kong · Delayed Price · Currency is HKD 1.640
-0.030 (-1.80%)
Jul 31, 2026, 4:08 PM HKT
HKG:2159 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 571.88 | 468.02 | 321.56 | 331.31 | 323.37 | 708.36 | |
Revenue Growth | 22.19% | 45.55% | -2.94% | 2.45% | -54.35% | 63.86% |
Cost of Revenue | 429.22 | 373.31 | 270.55 | 301.41 | 290.82 | 614.76 |
Gross Profit | 142.66 | 94.71 | 51 | 29.9 | 32.55 | 93.6 |
Selling, General & Admin | 62.92 | 63.7 | 60.59 | 73.35 | 75.56 | 75.84 |
Research & Development | 51.4 | 27.94 | 18.68 | 32.69 | 50.61 | 18.7 |
Operating Expenses | 117.32 | 92.89 | 87.21 | 111.81 | 129.59 | 86.92 |
Operating Income | 25.35 | 1.82 | -36.21 | -81.92 | -97.04 | 6.67 |
Interest Expense | -1.54 | -1.44 | -1.09 | -1.3 | -1.25 | -1.26 |
Interest & Investment Income | 0.24 | 0.24 | 0.26 | 0.42 | 0.62 | 0.79 |
Currency Exchange Gain (Loss) | -2.33 | -2.33 | 0.73 | 0.48 | 2.79 | -0.77 |
Other Non Operating Income (Expenses) | -1.41 | 0.09 | 0.19 | 3.17 | 2.47 | -0.86 |
EBT Excluding Unusual Items | 20.32 | -1.61 | -36.11 | -79.16 | -92.41 | 4.57 |
Gain (Loss) on Sale of Investments | 0.49 | 0.49 | 0.46 | 2.19 | 1.27 | 1.03 |
Gain (Loss) on Sale of Assets | -1.72 | -1.72 | -0.06 | -0.05 | - | -0.02 |
Asset Writedown | 9.26 | 9.26 | -11.68 | -20.45 | - | - |
Other Unusual Items | 0.56 | 0.56 | 2.21 | 1.09 | 0.1 | - |
Pretax Income | 28.91 | 6.98 | -45.17 | -96.38 | -91.04 | 5.59 |
Income Tax Expense | - | - | 1.78 | -0.29 | 2.71 | 0.39 |
Earnings From Continuing Operations | 28.91 | 6.98 | -46.95 | -96.09 | -93.74 | 5.2 |
Minority Interest in Earnings | 5.11 | 3.01 | 1.7 | 2 | 4.54 | -0.56 |
Net Income | 34.01 | 9.99 | -45.25 | -94.1 | -89.2 | 4.65 |
Net Income to Common | 34.01 | 9.99 | -45.25 | -94.1 | -89.2 | 4.65 |
Net Income Growth | 240.55% | - | - | - | - | -77.92% |
Shares Outstanding (Basic) | 246 | 228 | 191 | 191 | 186 | 181 |
Shares Outstanding (Diluted) | 246 | 228 | 191 | 191 | 186 | 182 |
Shares Change | 8.05% | 19.12% | - | 3.03% | 1.98% | 21.48% |
EPS (Basic) | 0.14 | 0.04 | -0.24 | -0.49 | -0.48 | 0.03 |
EPS (Diluted) | 0.14 | 0.04 | -0.24 | -0.49 | -0.48 | 0.03 |
EPS Growth | 215.18% | - | - | - | - | -81.82% |
Free Cash Flow | - | 3.44 | -15.02 | -76.98 | -19.87 | -2.06 |
Free Cash Flow Per Share | - | 0.01 | -0.08 | -0.40 | -0.11 | -0.01 |
Gross Margin | 24.95% | 20.24% | 15.86% | 9.02% | 10.07% | 13.21% |
Operating Margin | 4.43% | 0.39% | -11.26% | -24.73% | -30.01% | 0.94% |
Profit Margin | 5.95% | 2.13% | -14.07% | -28.40% | -27.58% | 0.66% |
Free Cash Flow Margin | - | 0.74% | -4.67% | -23.24% | -6.14% | -0.29% |
EBITDA | 26.24 | 2.81 | -34.6 | -79.32 | -93.79 | 11.32 |
EBITDA Margin | 4.59% | 0.60% | -10.76% | -23.94% | -29.00% | 1.60% |
D&A For EBITDA | 0.9 | 0.99 | 1.61 | 2.6 | 3.25 | 4.65 |
EBIT | 25.35 | 1.82 | -36.21 | -81.92 | -97.04 | 6.67 |
EBIT Margin | 4.43% | 0.39% | -11.26% | -24.73% | -30.01% | 0.94% |
Effective Tax Rate | - | - | - | - | - | 6.91% |